Latest News

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center in collaboration with Developmental Disabilities Health Alliance of New York and Community Resource Center for the Developmentally Disabled, Inc., have received a $2.4 million grant to integrate medical and mental healthcare for children and adults with intellectual and developmental disabilities. The grant was provided by the New York State Balancing Incentive Program Innovation Fund.

• share
• favorite_border

Rates of depression and anxiety vary widely among different segments of the U.S. Hispanic and Latino population, with the highest prevalence of depressive symptoms in Puerto Ricans, according to a new report from Albert Einstein College of Medicine of Yeshiva University and the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). The researchers’ findings also suggest that depression and anxiety may be undertreated among Hispanics and Latinos, particularly if they are uninsured. The study was published online in Annals of Epidemiology.

• share
• favorite_border

• share
• favorite_border

A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that measuring how fast the brain responds to sights and sounds could help in objectively classifying people on the autism spectrum and may help diagnose the condition earlier. The paper was published today in the online edition of the Journal of Autism and Developmental Disorders.

• share
• favorite_border

Researchers from Albert Einstein College of Medicine of Yeshiva University and other institutions have developed a potential antibody therapy for Sudan ebolavirus (SUDV), one of the two most lethal strains of Ebola. A different strain, the Zaire ebolavirus (EBOV), is now devastating West Africa. First identified in 1976, SUDV has caused numerous Ebola outbreaks (most recently in 2012) that have killed more than 400 people in total. The findings were reported in ACS Chemical Biology.

• share
• favorite_border

The National Institutes of Health (NIH) has awarded $9 million to renew a grant headed by Robert Callender, Ph.D., professor of biochemistry at Albert Einstein College of Medicine of Yeshiva University. He and his fellow researchers are working to develop drugs by considering the dynamics—including specific atomic motions—of the enzymes that those drugs target.

• share
• favorite_border

Frailty is a common condition associated with old age, characterized by weight loss, weakness, decreased activity level and reduced mobility, which together increase the risk of injury and death. Yet, not all elderly people become frail; some remain vigorous and robust well into old-age. The question remains: why?

• share
• favorite_border

Scientists at Albert Einstein College of Medicine of Yeshiva University have found that bacteria that aid in digestion help keep the intestinal lining intact. The findings, reported online in the journal Immunity, could yield new therapies for inflammatory bowel disease (IBD) and a wide range of other disorders.

• share
• favorite_border

A study involving nearly 27,000 older adults on five continents found that nearly 1 in 10 met criteria for pre-dementia based on a simple test that measures how fast people walk and whether they have cognitive complaints. People who tested positive for pre-dementia were twice as likely as others to develop dementia within 12 years. The study, led by scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, was published online on July 16, 2014 in Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have received a grant from The Michael J. Fox Foundation for Parkinson’s Research to translate a basic science finding into a treatment for Parkinson’s disease. This drug discovery project will test chemical compounds on a newly identified target with the goal of developing a drug that acts on an underlying cause of the disease.

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $2.5 million grant from the Agency for Healthcare Research and Quality (AHRQ) to establish a training program to improve the practice of healthcare in real-world settings. The program, in an emerging area called patient-centered outcomes research (PCOR), will be housed in the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore and will prepare established and junior investigators to initiate and lead research in this area.

• share
• favorite_border

The National Cancer Institute, part of the National Institutes of Health, has awarded a $10 million grant to researchers at Albert Einstein College of Medicine of Yeshiva University to fund research into how breast cancer cells move and spread in the body, and how to predict which breast cancer tumors will metastasize.

• share
• favorite_border

The study was led by researchers at the National Cancer Institute (NCI)─designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and Montefiore Einstein Center for Cancer Care and was published online today in the Journal of the National Cancer Institute (JNCI).

• share
• favorite_border

Research by scientists at Albert Einstein College of Medicine may help explain how some cases of autism spectrum disorder (ASD) can result from environmental influences rather than gene mutations. The findings, published online today in PLOS Genetics, shed light on why older mothers are at increased risk for having children with ASD and could pave the way for more research into the role of environment on ASD.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a signaling pathway in cancer cells that controls their ability to invade nearby tissues in a finely orchestrated manner. The findings offer insights into the early molecular events involved in metastasis, the deadly spread of cancer cells from primary tumor to other parts of the body. The study was published today in the online edition of Nature Cell Biology.

• share
• favorite_border

For otherwise healthy middle-aged women who are overweight or obese, physical activity may be their best option for avoiding heart disease, according to a study that followed nearly 900 women for seven years. These findings were reported in a paper led by authors at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, and published today in the Journal of Clinical Endocrinology & Metabolism.

• share
• favorite_border

Healthy stem cells work to restore or repair the body’s tissues, but cancer stem cells have a more nefarious mission: to spawn malignant tumors. Cancer stem cells were discovered a decade ago, but their origins and identity remain largely unknown.

• share
• favorite_border

Two risk factors – getting older and eating poorly – are implicated in more than 80 percent of colon cancer cases in developed countries. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have received a $3.2 million grant from the National Institutes of Health (NIH) to investigate how aging and poor nutrition interact to cause the mutations responsible for driving colon cancer development.

• share
• favorite_border

From uncovering the role nerve cells play in metastasis to identifying new cancer-causing genes, researchers at Albert Einstein College of Medicine of Yeshiva University made notable advances in the understanding and potential treatment of cancer during the past year. Several Einstein faculty members and students will present their recent research at the American Association for Cancer Research (AACR) Annual Meeting, taking place in San Diego April 5-9, 2014.

• share
• favorite_border

Members of the class of 2014 at Albert Einstein College of Medicine continued a time-honored medical school tradition when they ripped open their personalized envelopes and learned where they will launch their careers as a doctors. On Match Day, fourth-year students at Einstein – and at medical schools around the country – discover where and in what specialty they will conduct their residency training. Residency begins after medical school graduation.

• share
• favorite_border

Albert Einstein College of Medicine helps establish new $28 million consortium to find antibody treatments for Ebola and other viruses.

• share
• favorite_border

The Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the landmark research study of Hispanic/Latino health funded by the National Institutes of Health (NIH), has released initial findings that show significant variations in disease prevalence and health behaviors among groups with different backgrounds.

• share
• favorite_border

A study led by Albert Einstein College of Medicine researcher Dr. Scott Emmons has been named the most outstanding Science paper published last year by AAAS. Dr. Emmons’ paper describes the complete wiring diagram for the part of the nervous system that controls mating behavior in male roundworms.

• share
• favorite_border

When the foe is a disease-causing microbe, identifying the structure of its component proteins can greatly aid efforts to kill or disable it. Research to gain this knowledge will be bolstered by a $3 million grant from The Price Family Foundation. The gift to Albert Einstein College of Medicine of Yeshiva University and the University of Oklahoma funds a research collaboration to investigate the structural biology of the key proteins of anaerobic microorganisms (those that don’t use oxygen).

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical “signature” in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.

• share
• favorite_border

In two studies in the January 24 issue of Science, researchers at Albert Einstein College of Medicine used advanced imaging techniques to provide a window into how the brain makes memories. These insights into the molecular basis of memory were made possible by a technological tour de force never before achieved in animals: a mouse model developed at Einstein in which molecules crucial to making memories were given fluorescent “tags” so they could be observed traveling in real time in living brain cells.

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University ranked among the top fifth of medical schools in securing research funding from the National Institutes of Health (NIH) in 2013. The rankings were provided by the Blue Ridge Institute for Medical Research, a non-profit organization based in North Carolina that compares research funding at medical schools using an open access NIH database.

• share
• favorite_border

Mark Kuniholm, Ph.D., was on the Einstein research team that found that the prevalence of Hepatitis C varies widely among different Hispanic groups in the U.S.

• share
• favorite_border

Roadside bombs and other blasts have made head injury the “signature wound” of the Iraq and Afghanistan conflicts. Now, researchers at Albert Einstein College of Medicine of Yeshiva University, in cooperation with Resurrecting Lives Foundation, are investigating the effect of repeated combat-related blast exposures on the brains of veterans with the goal of improving diagnostics and treatment.

• share
• favorite_border

More women are choosing science careers, yet women are notoriously underrepresented in senior academic positions—often because they abandon their careers due to pessimism about advancement. New research suggests that putting more women in decision-making roles on the teams that organize symposia could offer a simple, effective step forward.